Phase II Study of Docetaxel and Capecitabine in Patients with Metastatic or Recurrent Gastric Cancer

Publisher： Karger

E-ISSN： 1423-0232|68|2-3|190-195

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.2-3, 2005-07, pp. : 190-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Pilot Phase II Study of Capecitabine in Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 64, Iss. 3, 2003-04 ,pp. : 232-236

Karger

Access to resources Recommend Favorite

A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Phase II Study of Biweekly Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 77, Iss. 1, 2009-06 ,pp. : 49-52

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 356-363

Karger

Access to resources Recommend Favorite